European Union and AstraZeneca both claim victory after COVID-19 vaccine fight

European Union and AstraZeneca both claim victory after COVID-19 vaccine fight

European Union and AstraZeneca both claim victory after COVID-19 vaccine fight

National Advisory Committee on Immunization (NACI) is now recommending that individuals who received a single dose of the AstraZeneca COVID-19 vaccine be given an mRNA vaccine, Pfizer-BioNTech or Moderna vaccine, for their second dose.

Canada's national advisory panel on immunization said earlier this month that authorized Covid-19 vaccines could be mixed, and noted some people might prefer to get a messenger RNA vaccine for their second shot.

NACI's new advice did not change the Ontario government's position on AstraZeneca, with the province saying Friday that those who got a first shot of it could decide whether to get the same vaccine or a different mRNA shot as a second dose.

"It may in some people stimulate a stronger, perhaps more longer-lasting, immune response, so you may get the best of both worlds out of that", Dr. Bonnie Henry said.

VITT is a rare blood clot that has occurred in some people who received the AstraZeneca shot.

But AstraZeneca argued that the challenges of producing and delivering the vaccine could not have been foreseen during a once-in-a-century pandemic, and that its United Kingdom sites were primarily meant to be used to service its contract with the British government.

Canada expects to have fully vaccinated 75 per cent of all eligible Canadians - everyone over the age of 12 - by the end of July, and has administered 78 doses for every 100 Canadians.

After AstraZeneca-related blood clotting appeared around the world in young people, Henry suspended use of that vaccine for people aged under 30.

In Windsor-Essex, more than 37,000 people received their first dose of AstraZeneca before it stopped being offered as a first dose.

A Belgian court on Friday ordered drugs company AstraZeneca to deliver 50 million doses of its COVID-19 vaccine to European Union members by September 27, fewer than Brussels had demanded.

With AstraZeneca vaccine in shorter supply, the European Union seeks to expand use of the Pfizer-BioNTech vaccine. That was significantly less than the European Union demand for 120 million doses to be delivered by the end of June and for the full contract of 300 million doses to be fulfilled by the end of September.

"That is something that happens when we're in a global pandemic with a global vaccine supply".

There are no further shipments of AstraZeneca scheduled.

WATCH | Saskatoon ICU doctor describes the regret of dying COVID-19 patient who didn't get vaccinated Dr. Hassan Masri, an ICU specialist based in Saskatoon, said one patient who ended up dying from COVID-19 was regretful for not getting vaccinated against the virus. Almost 66% of the population had received at least one dose of a Covid-19 vaccine as of June 16, although just 15% of the population is fully vaccinated.

Related news

[an error occurred while processing the directive]